Bioinformatics and Network Pharmacology Identify the Therapeutic Role and Potential Mechanism of Melatonin in AD and Rosacea

Rosacea is significantly associated with dementia, particularly Alzheimer’s disease (AD). However, the common underlying molecular mechanism connecting these two diseases remains limited. This study aimed to reveal the common molecular regulatory networks and identify the potential therapeutic drugs...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Huaxiong Zhang, Yiya Zhang, Yangfan Li, Yaling Wang, Sha Yan, San Xu, Zhili Deng, Xinling Yang, Hongfu Xie, Ji Li
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
AD
MLT
Acceso en línea:https://doaj.org/article/151de9b290e04633b669aa2b5d8732ee
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:151de9b290e04633b669aa2b5d8732ee
record_format dspace
spelling oai:doaj.org-article:151de9b290e04633b669aa2b5d8732ee2021-12-01T02:59:45ZBioinformatics and Network Pharmacology Identify the Therapeutic Role and Potential Mechanism of Melatonin in AD and Rosacea1664-322410.3389/fimmu.2021.756550https://doaj.org/article/151de9b290e04633b669aa2b5d8732ee2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.756550/fullhttps://doaj.org/toc/1664-3224Rosacea is significantly associated with dementia, particularly Alzheimer’s disease (AD). However, the common underlying molecular mechanism connecting these two diseases remains limited. This study aimed to reveal the common molecular regulatory networks and identify the potential therapeutic drugs for rosacea and AD. There were 747 overlapped DEGs (ol-DEGs) that were detected in AD and rosacea, enriched in inflammation-, metabolism-, and apoptosis-related pathways. Using the TF regulatory network analysis, 37 common TFs and target genes were identified as hub genes. They were used to predict the therapeutic drugs for rosacea and AD using the DGIdb/CMap database. Among the 113 predicted drugs, melatonin (MLT) was co-associated with both RORA and IFN-γ in AD and rosacea. Subsequently, network pharmacology analysis identified 19 pharmacological targets of MLT and demonstrated that MLT could help in treating AD/rosacea partly by modulating inflammatory and vascular signaling pathways. Finally, we verified the therapeutic role and mechanism of MLT on rosacea in vivo and in vitro. We found that MLT treatment significantly improved rosacea-like skin lesion by reducing keratinocyte-mediated inflammatory cytokine secretion and repressing the migration of HUVEC cells. In conclusion, this study contributes to common pathologies shared by rosacea and AD and identified MLT as an effective treatment strategy for rosacea and AD via regulating inflammation and angiogenesis.Huaxiong ZhangHuaxiong ZhangHuaxiong ZhangYiya ZhangYiya ZhangYiya ZhangYangfan LiYangfan LiYaling WangYaling WangSha YanSha YanSan XuSan XuSan XuZhili DengZhili DengZhili DengXinling YangHongfu XieHongfu XieHongfu XieJi LiJi LiJi LiJi LiFrontiers Media S.A.articlerosaceaADMLTnetwork pharmacologyinflammationangiogenesisImmunologic diseases. AllergyRC581-607ENFrontiers in Immunology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic rosacea
AD
MLT
network pharmacology
inflammation
angiogenesis
Immunologic diseases. Allergy
RC581-607
spellingShingle rosacea
AD
MLT
network pharmacology
inflammation
angiogenesis
Immunologic diseases. Allergy
RC581-607
Huaxiong Zhang
Huaxiong Zhang
Huaxiong Zhang
Yiya Zhang
Yiya Zhang
Yiya Zhang
Yangfan Li
Yangfan Li
Yaling Wang
Yaling Wang
Sha Yan
Sha Yan
San Xu
San Xu
San Xu
Zhili Deng
Zhili Deng
Zhili Deng
Xinling Yang
Hongfu Xie
Hongfu Xie
Hongfu Xie
Ji Li
Ji Li
Ji Li
Ji Li
Bioinformatics and Network Pharmacology Identify the Therapeutic Role and Potential Mechanism of Melatonin in AD and Rosacea
description Rosacea is significantly associated with dementia, particularly Alzheimer’s disease (AD). However, the common underlying molecular mechanism connecting these two diseases remains limited. This study aimed to reveal the common molecular regulatory networks and identify the potential therapeutic drugs for rosacea and AD. There were 747 overlapped DEGs (ol-DEGs) that were detected in AD and rosacea, enriched in inflammation-, metabolism-, and apoptosis-related pathways. Using the TF regulatory network analysis, 37 common TFs and target genes were identified as hub genes. They were used to predict the therapeutic drugs for rosacea and AD using the DGIdb/CMap database. Among the 113 predicted drugs, melatonin (MLT) was co-associated with both RORA and IFN-γ in AD and rosacea. Subsequently, network pharmacology analysis identified 19 pharmacological targets of MLT and demonstrated that MLT could help in treating AD/rosacea partly by modulating inflammatory and vascular signaling pathways. Finally, we verified the therapeutic role and mechanism of MLT on rosacea in vivo and in vitro. We found that MLT treatment significantly improved rosacea-like skin lesion by reducing keratinocyte-mediated inflammatory cytokine secretion and repressing the migration of HUVEC cells. In conclusion, this study contributes to common pathologies shared by rosacea and AD and identified MLT as an effective treatment strategy for rosacea and AD via regulating inflammation and angiogenesis.
format article
author Huaxiong Zhang
Huaxiong Zhang
Huaxiong Zhang
Yiya Zhang
Yiya Zhang
Yiya Zhang
Yangfan Li
Yangfan Li
Yaling Wang
Yaling Wang
Sha Yan
Sha Yan
San Xu
San Xu
San Xu
Zhili Deng
Zhili Deng
Zhili Deng
Xinling Yang
Hongfu Xie
Hongfu Xie
Hongfu Xie
Ji Li
Ji Li
Ji Li
Ji Li
author_facet Huaxiong Zhang
Huaxiong Zhang
Huaxiong Zhang
Yiya Zhang
Yiya Zhang
Yiya Zhang
Yangfan Li
Yangfan Li
Yaling Wang
Yaling Wang
Sha Yan
Sha Yan
San Xu
San Xu
San Xu
Zhili Deng
Zhili Deng
Zhili Deng
Xinling Yang
Hongfu Xie
Hongfu Xie
Hongfu Xie
Ji Li
Ji Li
Ji Li
Ji Li
author_sort Huaxiong Zhang
title Bioinformatics and Network Pharmacology Identify the Therapeutic Role and Potential Mechanism of Melatonin in AD and Rosacea
title_short Bioinformatics and Network Pharmacology Identify the Therapeutic Role and Potential Mechanism of Melatonin in AD and Rosacea
title_full Bioinformatics and Network Pharmacology Identify the Therapeutic Role and Potential Mechanism of Melatonin in AD and Rosacea
title_fullStr Bioinformatics and Network Pharmacology Identify the Therapeutic Role and Potential Mechanism of Melatonin in AD and Rosacea
title_full_unstemmed Bioinformatics and Network Pharmacology Identify the Therapeutic Role and Potential Mechanism of Melatonin in AD and Rosacea
title_sort bioinformatics and network pharmacology identify the therapeutic role and potential mechanism of melatonin in ad and rosacea
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/151de9b290e04633b669aa2b5d8732ee
work_keys_str_mv AT huaxiongzhang bioinformaticsandnetworkpharmacologyidentifythetherapeuticroleandpotentialmechanismofmelatonininadandrosacea
AT huaxiongzhang bioinformaticsandnetworkpharmacologyidentifythetherapeuticroleandpotentialmechanismofmelatonininadandrosacea
AT huaxiongzhang bioinformaticsandnetworkpharmacologyidentifythetherapeuticroleandpotentialmechanismofmelatonininadandrosacea
AT yiyazhang bioinformaticsandnetworkpharmacologyidentifythetherapeuticroleandpotentialmechanismofmelatonininadandrosacea
AT yiyazhang bioinformaticsandnetworkpharmacologyidentifythetherapeuticroleandpotentialmechanismofmelatonininadandrosacea
AT yiyazhang bioinformaticsandnetworkpharmacologyidentifythetherapeuticroleandpotentialmechanismofmelatonininadandrosacea
AT yangfanli bioinformaticsandnetworkpharmacologyidentifythetherapeuticroleandpotentialmechanismofmelatonininadandrosacea
AT yangfanli bioinformaticsandnetworkpharmacologyidentifythetherapeuticroleandpotentialmechanismofmelatonininadandrosacea
AT yalingwang bioinformaticsandnetworkpharmacologyidentifythetherapeuticroleandpotentialmechanismofmelatonininadandrosacea
AT yalingwang bioinformaticsandnetworkpharmacologyidentifythetherapeuticroleandpotentialmechanismofmelatonininadandrosacea
AT shayan bioinformaticsandnetworkpharmacologyidentifythetherapeuticroleandpotentialmechanismofmelatonininadandrosacea
AT shayan bioinformaticsandnetworkpharmacologyidentifythetherapeuticroleandpotentialmechanismofmelatonininadandrosacea
AT sanxu bioinformaticsandnetworkpharmacologyidentifythetherapeuticroleandpotentialmechanismofmelatonininadandrosacea
AT sanxu bioinformaticsandnetworkpharmacologyidentifythetherapeuticroleandpotentialmechanismofmelatonininadandrosacea
AT sanxu bioinformaticsandnetworkpharmacologyidentifythetherapeuticroleandpotentialmechanismofmelatonininadandrosacea
AT zhilideng bioinformaticsandnetworkpharmacologyidentifythetherapeuticroleandpotentialmechanismofmelatonininadandrosacea
AT zhilideng bioinformaticsandnetworkpharmacologyidentifythetherapeuticroleandpotentialmechanismofmelatonininadandrosacea
AT zhilideng bioinformaticsandnetworkpharmacologyidentifythetherapeuticroleandpotentialmechanismofmelatonininadandrosacea
AT xinlingyang bioinformaticsandnetworkpharmacologyidentifythetherapeuticroleandpotentialmechanismofmelatonininadandrosacea
AT hongfuxie bioinformaticsandnetworkpharmacologyidentifythetherapeuticroleandpotentialmechanismofmelatonininadandrosacea
AT hongfuxie bioinformaticsandnetworkpharmacologyidentifythetherapeuticroleandpotentialmechanismofmelatonininadandrosacea
AT hongfuxie bioinformaticsandnetworkpharmacologyidentifythetherapeuticroleandpotentialmechanismofmelatonininadandrosacea
AT jili bioinformaticsandnetworkpharmacologyidentifythetherapeuticroleandpotentialmechanismofmelatonininadandrosacea
AT jili bioinformaticsandnetworkpharmacologyidentifythetherapeuticroleandpotentialmechanismofmelatonininadandrosacea
AT jili bioinformaticsandnetworkpharmacologyidentifythetherapeuticroleandpotentialmechanismofmelatonininadandrosacea
AT jili bioinformaticsandnetworkpharmacologyidentifythetherapeuticroleandpotentialmechanismofmelatonininadandrosacea
_version_ 1718405887154978816